申请人:Amgen Inc.
公开号:US20040029863A1
公开(公告)日:2004-02-12
Selected novel carboxylic acid substituted heterocycle compounds are effective for prophylaxis and treatment of inflammation, tissue degradation, cancer, fibrosis and related diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of inflamation, tissue degradation and related diseases. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
选定的新型羧酸取代杂环化合物对预防和治疗炎症、组织退化、癌症、纤维化及相关疾病有效。本发明涵盖了新型化合物、类似物、前药和其药学上可接受的盐、药物组合物以及预防和治疗炎症、组织退化和相关疾病的方法。该发明还涉及制备这些化合物的方法,以及在这些过程中有用的中间体。